AMRA Appoints Eric Converse as CEO
Summary
LINKÖPING, Sweden--( BUSINESS WIRE )--AMRA Medical (“AMRA”), the international leader in body composition analysis, announced today that Eric Converse has been appointed as its new Chief Executive Officer (CEO).Most recently, Converse has been working with large pharmaceutical companies on potential and current investments and projects focused on real-world data (RWD) and real-world evidence (RWE).In addition to a specialty in uniting international teams to meet and exceed customer requirements, Converse has over 15 years of further experience holding multiple CEO roles and Board positions across a variety of companies and industries in the US and Europe.The company has developed a new global standard in body composition assessment, the ability to automatically produce multiple fat and muscle biomarkers with unrivaled precision and accuracy, as well as contextual disease insights – all from a single, 6-minute, whole-body MRI.AMRA was founded in 2010 as a spin-off of Linköping University, Sweden, with the aim to support transformative care and vital decision-making from clinical research to health and wellness.